ERIKO SAITO: Open Payments
NPI 1881427359 · BELTSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $139 |
| KYOWA KIRIN, INC. | 1 | $122 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $97 |
| Alexion Pharmaceuticals, Inc. | 1 | $94 |
Products named: INGREZZA.
Industry payments across MD — which companies pay providers there.
